Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
196 studies found for:    Restless Legs Syndrome
Show Display Options
Rank Status Study
21 Recruiting Restless Leg Syndrome and Severe Preeclampsia
Conditions: Restless Leg Syndrome;   Severe Preeclampsia
22 Active, not recruiting Switching From Oral Dopamine Agonists to Rotigotine
Conditions: Restless Legs Syndrome;   Ekbom Syndrome;   Willis-Ekbom Disease
Intervention: Drug: Rotigotine
23 Completed A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
Conditions: Restless Legs Syndrome;   Restless Legs Syndrome (RLS)
Intervention: Drug: Ropinirole
24 Completed
Has Results
Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients
Condition: Restless Legs Syndrome
Interventions: Drug: placebo;   Drug: Pregabalin
25 Completed Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy
Conditions: Restless Leg Syndrome;   Iron Deficiency Anemia
Intervention: Drug: ferric carboxymaltose
26 Completed
Has Results
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
Conditions: Restless Legs Syndrome;   End-Stage Renal Disease
Interventions: Drug: Rotigotine;   Drug: Placebo
27 Unknown  Neuroma Injections to Treat Restless Legs Syndrome - RCT
Condition: Restless Legs Syndrome
Interventions: Drug: equal parts of 0.5% plain Marcaine and 2% lidocaine mixed with 0.8 mg Depo-medrol/4% absolute alcohol in a total injection volume of 1 ml;   Drug: Normal saline - 1ml
28 Completed
Has Results
Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance
Condition: Restless Legs Syndrome
Interventions: Drug: pregabalin;   Drug: placebo;   Drug: pramipexole
29 Completed
Has Results
Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Interventions: Drug: Pramipexole;   Drug: Placebo
30 Withdrawn 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects
Condition: Restless Legs Syndrome
Interventions: Drug: Placebo;   Drug: pregabalin
31 Completed Restless Legs Syndrome Treatment With Botulinum Toxin
Condition: Restless Legs Syndrome
Intervention: Drug: BNT (intradermal injection)
32 Completed
Has Results
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Condition: Restless Leg Syndrome
Interventions: Drug: incobotulinumtoxinA;   Drug: Placebo
33 Completed RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Conditions: Restless Legs Syndrome;   Restless Legs Syndrome (RLS)
Intervention: Drug: ropinirole Extended Release (XR)
34 Completed
Has Results
Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Rotigotine;   Drug: Placebo
35 Unknown  Restless Legs Syndrome Exercise Intervention
Conditions: Restless Legs Syndrome;   Insomnia
Intervention: Behavioral: Aerobic exercise
36 Completed Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome
Conditions: Sleep Disorder;   Restless Legs Syndrome
Intervention: Drug: Istradefylline (KW-6002)
37 Completed
Has Results
The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome
Conditions: Restless Legs Syndrome;   Moderate to Severe Idiopathic Restless Legs Syndrome (RLS)
Intervention: Drug: Ropinirole
38 Completed
Has Results
Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
Condition: Idiopathic Restless Legs Syndrome
Interventions: Drug: SPM 962;   Drug: Placebo of SPM 962
39 Completed Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Ropinirole Extended Release (XR)
40 Withdrawn IV Iron Treatment of Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Iron isomaltoside 1000;   Drug: Sodium Chloride 0.9%

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years